Search Options Stock News and Analysis from Schaeffer's

AstraZeneca Stock Sinks After $32 Billion Acquisition

https://www.schaeffersresearch.com/content/options/2020/12/14/astrazeneca-stock-sinks-after-32-billion-acquisition

12/14/2020 2:47 PM

AstraZeneca plc (NASDAQ:AZN) is sinking this afternoon, off 7% at $50.52 at last check, after the pharmaceutical giant and COVID-19 vaccine hopeful agreed to buy Alexion Pharmaceuticals, Inc. (NASDA...

Pharma Stock Boosted by Upped Guidance

https://www.schaeffersresearch.com/content/news/2020/10/06/pharma-stock-boosted-by-upped-guidance

10/6/2020 10:35 AM

Alexion Pharmaceuticals Inc (NASDAQ:ALXN) is climbing higher today, up 3.7% at $119.50 at last check, after word that the company plans to raise its 2020 full-year guidance. On Oct. 28, the estimated ...

3 Underperforming Pharma Stocks Trying to Bounce Back

https://www.schaeffersresearch.com/content/news/2019/09/26/3-underperforming-pharma-stocks-trying-to-bounce-back

9/26/2019 10:49 AM

This morning we're looking at Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), and Marinus Pharmaceuticals Inc (NASDAQ:MRNS). All three pharma stocks have had...

2 Reasons to Like This Pharma Stock Right Now

https://www.schaeffersresearch.com/content/analysis/2019/05/29/2-reasons-to-like-this-pharma-stock-right-now

5/29/2019 12:34 PM

Like most of the stock market, the shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have struggled in May, down nearly 10% so far. However, now could be an opportune time to roll the dice on a ...

2 Surging Drug Stocks Seeing Heavy Options Trading

https://www.schaeffersresearch.com/content/news/2018/09/26/2-surging-drug-stocks-seeing-heavy-options-trading

9/26/2018 3:18 PM

The U.S. stock market is mixed at midday, as traders digest the latest policy news from the Fed. Among individual names in focus are Soliris maker Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Lyme D...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity